Resource Library
Samsung Biologics Bispecific Antibody Platform - A novel asymmetrical structure for therapeutic antibodies
Herein, we introduce a Samsung Biologics proprietary bispecific antibody platform (SBL9), which enables strongly orthogonal pairing of heavy and light chains to ensure the desired formation of multiple chains.
Herein, we introduce a Samsung Biologics proprietary bispecific antibody platform (SBL9), which enables strongly orthogonal pairing of heavy and light chains to ensure the desired formation of multiple chains.